Seasoned investor and operator focused on private equity and real estate capital strategies. DONNALEE GUERIN is a senior executive with experience sourcing deals, structuring transactions and managing portfolio companies across asset-heavy sectors. Known for blending operational oversight with capital markets discipline, she has advised on growth financings, restructurings and exits. Market-facing skills include investor relations, due diligence and cross-border transaction execution.
Seasoned investor and operator focused on private equity and real estate capital strategies. DONNALEE GUERIN is a senior executive with experience sourcing deals, structuring transactions and managing portfolio companies across asset-heavy sectors. Known for blending operational oversight with capital markets discipline, she has advised on growth financings, restructurings and exits. Market-facing skills include investor relations, due diligence and cross-border transaction execution.
Combines operationally driven private equity and real estate investing with disciplined capital-structure engineering to unlock value in asset-heavy sectors. Prioritizes control or influential minority positions where hands-on governance, operational turnaround, and growth-capital deployment accelerate cash flow improvement and multiple expansion. Underwrites deals with scenario-based downside protection, liquidity pathway planning and staged financing. Time horizon is medium-to-long term with active portfolio management, regular KPI-driven interventions, and exit preparation via strategic sale, refinancing or public-market pathways. Cross-border execution and investor-relations discipline support complex transactions.
Combines operationally driven private equity and real estate investing with disciplined capital-structure engineering to unlock value in asset-heavy sectors. Prioritizes control or influential minority positions where hands-on governance, operational turnaround, and growth-capital deployment accelerate cash flow improvement and multiple expansion. Underwrites deals with scenario-based downside protection, liquidity pathway planning and staged financing. Time horizon is medium-to-long term with active portfolio management, regular KPI-driven interventions, and exit preparation via strategic sale, refinancing or public-market pathways. Cross-border execution and investor-relations discipline support complex transactions.
| Trades 2021 | Longs Won 1308/2021 64% | Profit Factor 28.47 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $4.05M |
| Average Win $456,103.19 | Best Trade (Oct 15) $126.05M | Sharpe Ratio -12.92 |
| Average Loss -$29,392.49 | Worst Trade (Dec 31) -$4.62M | Z-Score 3.29 (99.9%) |
| Commissions $0 | Avg. Trade Length 1y 2m 4w | Expectancy $284,822.43 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.13% |
| Consecutive Losing Trades | 62,500 | 56,250 | 50,000 | 43,750 | 37,500 | 31,250 | 25,000 | 18,750 | 12,500 | 6,250 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,320 | $183,831 | $229,363.2 | - | $45,532.2 | 24.77% | -1.02% |
AAPL Apple Inc. | 93,009 | $19M | $32.03M | - | $13.03M | 68.57% | +0.69% |
ABBV AbbVie Inc. | 3,815 | $686,382.07 | $1.09M | - | $400,721.25 | 58.38% | +0.549% |
ABT Abbott Laboratories | 5,698 | $687,087.94 | $596,723.05 | - | -$90,364.89 | -13.15% | +0.043% |
ACN Accenture plc Class A | 276 | $79,415.7 | $62,584.38 | - | -$16,831.32 | -21.19% | +0.816% |
ADI Analog Devices, Inc. | 997 | $219,352.47 | $405,350.29 | - | $185,997.82 | 84.79% | +0.649% |
ADP Automatic Data Processing Inc. | 3,120 | $781,631.43 | $893,474.4 | - | $111,842.97 | 14.31% | +0.252% |
AEE Ameren Corporation | 487 | $37,440.31 | $51,466.16 | - | $14,025.85 | 37.46% | +1.85% |
AEP American Electric Power Company, Inc. | 25 | $2,837.88 | $3,167 | - | $329.12 | 11.6% | +1.923% |
ALB Albemarle Corporation | 7 | $993 | $678.65 | - | -$314.35 | -31.66% | -1.253% |
AMAT Applied Materials, Inc. | 320 | $65,315.29 | $133,907.2 | - | $68,591.91 | 105.02% | -2.686% |
AMD Advanced Micro Devices, Inc. | 189 | $30,754.49 | $102,528.72 | - | $71,774.23 | 233.38% | -3.513% |
AMGN Amgen Inc. | 420 | $121,444.52 | $182,817.6 | - | $61,373.08 | 50.54% | +0.288% |
AMP Ameriprise Financial, Inc. | 19 | $9,316 | $9,513.3 | - | $197.3 | 2.12% | -0.374% |
AMZN Amazon.com Inc | 234,823 | $36.21M | $59.06M | - | $22.85M | 63.11% | -1.27% |
APH Amphenol Corporation | 1.96M | $24.98M | $157.69M | - | $132.71M | 531.15% | -1.307% |
APO Apollo Global Management, Inc. | 36 | $5,211 | $4,060.08 | - | -$1,150.92 | -22.09% | +0.813% |
ARKK ARK Innovation ETF Fund | 244 | $12,778 | $20,160.5 | - | $7,382.5 | 57.78% | -3.577% |
ASML ASML Holding N.V. New York Registry Shares | 68 | $56,660.77 | $113,205.72 | - | $56,544.95 | 99.8% | +0.443% |
ATAI AtaiBeckley Inc. | 2,045 | $10,777 | $10,777 | - | - | - | 0.0 |